Form 8-K - Current report:
SEC Accession No. 0001558370-22-019017
Filing Date
2022-12-28
Accepted
2022-12-28 16:18:35
Documents
15
Period of Report
2022-12-21
Items
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K rsls-20221221x8k.htm   iXBRL 8-K 37495
2 EX-3.1 rsls-20221221xex3d1.htm EX-3.1 14551
3 EX-99.1 rsls-20221221xex99d1.htm EX-99.1 9841
4 GRAPHIC rsls-20221221xex99d1001.jpg GRAPHIC 6993
  Complete submission text file 0001558370-22-019017.txt   199433

Data Files

Seq Description Document Type Size
5 EX-101.SCH rsls-20221221.xsd EX-101.SCH 3107
6 EX-101.LAB rsls-20221221_lab.xml EX-101.LAB 15895
7 EX-101.PRE rsls-20221221_pre.xml EX-101.PRE 10251
9 EXTRACTED XBRL INSTANCE DOCUMENT rsls-20221221x8k_htm.xml XML 4905
Mailing Address 1001 CALLE AMANECER SAN CLEMENTE CA 92673
Business Address 1001 CALLE AMANECER SAN CLEMENTE CA 92673 949-429-6680
ReShape Lifesciences Inc. (Filer) CIK: 0001427570 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37897 | Film No.: 221494762
SIC: 3841 Surgical & Medical Instruments & Apparatus